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Recent advances in genetic engineering have resulted in exponential growth in cell therapy technologies. This 
has led to a need for corresponding advances in the cell culture media that is used to recover, sustain and expand 
these important cells.  Cell therapy researchers and manufacturers alike, have spent valuable time and money to 
optimize media formulations to enhance cell proliferation while maintaining functional capabilities of stem cells 
and immune cells. Serum free (SFM) and/or chemically defined formulations are thought to be superior due to the 
appearance that they are safer.  However, proliferation rates and cell robustness often suffer due to the lack of 
physiologically relevant protein sources and concentrations.  Therefore, there is a need for enhanced media 
supplements to help the cell therapy market thrive. PhysiologixTM XF Human Growth Factor Concentrate (hGFC) 
is a cell culture media supplement that can be used in place of serum supplements with traditional basal media 
such as RPMI 1640 or DMEM/F12.  
In this study, hGFC was compared to various serum free media.  CD4+ T cells were isolated from the blood of 
three donors using standard protocol. Cells were labeled with CFSE and cultured over 7 days in RPMI 1640, 
Glutamax and 2% hGFC or SFM. Cells were collected on days 1,2,4 and 7, stained with Ghost Dye 780 for viability 
gating on flow cytometer and assayed using CFSE to determine proliferation. Bone marrow derived mesenchymal 
stem cells (BM-MSC) were purchased from ATCC. 
Culture conditions included DMEM/F12 
supplemented with 2% hGFC or SFM. Cells were 
assayed using Cell Titer Blue. Induced pluripotent 
stem cells (iPSC) were purchased from Thermo 
Fisher Scientific. Culture conditions included Culture 
conditions included DMEM/F12 supplemented with 
2% hGFC or SFM. Cells were assayed using Cell 
Titer Glo.  
Figure 1 shows the difference in overall cell number 
after a week of culture in commercially available basal 
media supplemented with PhysiologixTM XF hGFC. 
Figure 1A shows the BM-MSC grow in a similar 
fashion compared to commercially available SFM for 
the first few days after which the proliferation 
becomes markedly increased in the PhysiologixTM 
condition. Similarly Figure 1B-C depicts a similar 
trend in iPSC and CD4+ T cells.  
The implications of this data are particularly important 
for those in cell therapy manufacturing where cell proliferation rate is critical. Cell growth is not the only 
characteristic of importance to those in cell therapy manufacturing.  Future work is aimed at ensuring that cells 
grown in PhysiologixTM XF media maintain phenotypic fidelity and functional capabilities.    
 
Figure 1. Proliferation of BM-MSC when grown in five 




Figure 2. Proliferation of BM-MSC (A), iPSC (B) and CD4+ T cells (C) when grown for the indicated time in 
Physiologix supplemented media compared to industry leading serum free media. 
 
